Ansamycin Inhibitors of Hsp90: Nature's Prototype for Anti-Chaperone Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|9|15|1386-1418

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.9, Iss.15, 2009-11, pp. : 1386-1418

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of the HSP90 Molecular Chaperone: Attacking the Master Regulator in Cancer

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 11, 2006-06 ,pp. : 1091-1107

Bentham Science Publishers

Access to resources Recommend Favorite

Effectiveness of Hsp90 Inhibitors as Anti-Cancer Drugs

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 10, 2006-10 ,pp. : 1137-1143

Bentham Science Publishers

Access to resources Recommend Favorite

Preface [Hot topic:Hsp90 Molecular Chaperone Inhibitors: Opportunities and Challenges (Guest Editor: Paul Workman)]

By  

Current Cancer Drug Targets, Vol. 3, Iss. 5, 2003-10 ,pp. : i-i

Bentham Science Publishers

Access to resources Recommend Favorite

Macrocyclic Inhibitors of Hsp90

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 14, 2010-10 ,pp. : 1380-1402

Bentham Science Publishers

Access to resources Recommend Favorite

Medicinal Chemistry of Hsp90 Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 10, 2008-07 ,pp. : 859-868

Bentham Science Publishers

Access to resources Recommend Favorite